Who Is Ankiti Bose? Terra Invest Founding Partner, Longevity Investor and AI Healthcare Builder

Ankiti Bose is an entrepreneur, investor and company builder working at the intersection of capital, technology, healthcare, longevity, finance, policy and emerging markets. She is one of the Founding Partners of Terra-Invest, where she focuses on ambitious investment and operating initiatives across energy transition, healthcare, finance, technology, trade finance, strategic capital platforms and pre-IPO opportunities.

Today, Bose’s work is increasingly centred on the future of healthcare, particularly AI-powered longevity, preventive health, diagnostics, aesthetics, consumer health platforms and next-generation health optimisation across the Middle East, Europe and India.

Ankiti Bose and Terra-Invest

At Terra-Invest, Ankiti Bose works across investment themes that sit at the edge of capital, policy and real-world industry transformation. Terra-Invest focuses on high-growth sectors such as energy transition, healthcare, finance, technology, strategic capital platforms and pre-IPO opportunities.

Bose’s work through Terra-Invest reflects a broader thesis: the next generation of category-defining companies will not be built in silos. They will emerge where institutional capital, governance, artificial intelligence, consumer trust, frontier markets and distribution come together.

For Ankiti Bose, Terra-Invest is not only an investment platform. It is a vehicle for building and backing companies that can move from niche to category-defining, especially in sectors where technology, science, regulation, brand and capital compound together.

Chairperson of Terra’s Future Health Group

Ankiti Bose is also Chairperson of Terra’s Future Health Group, which invests in and manages AI-powered longevity, aesthetics and consumer health platforms and longevity clinics across the Middle East and Europe.

The group is built around a simple belief: the future of healthcare will be predictive, personalised, preventive and performance-led.

Through Terra’s Future Health Group, Bose is involved in platforms operating across AI-led diagnostics, precision medicine, telehealth, longevity clinics, regenerative wellness, aesthetics, performance health and next-generation health optimisation. The group is designed for people who want to live longer, healthier and better lives, not just by treating illness, but by tracking, optimising and improving healthspan.

Building at the Intersection of AI Healthcare and Longevity

The global longevity industry is rapidly moving beyond wellness trends into a more serious, data-led and medically integrated category. Ankiti Bose’s work in this space is focused on the convergence of AI healthcare, diagnostics, biomarkers, precision and preventive medicine, aesthetics, regenerative protocols and consumer platforms.

Terra’s Future Health Group operates with the view that healthcare will increasingly shift from reactive treatment to early detection, personalised intervention and continuous optimisation. This means using diagnostics, data, doctors, science and technology to help individuals understand what is happening inside their bodies earlier and more precisely.

For Bose, longevity is not only about living longer. It is about building systems that allow people to live with more energy, resilience, performance and confidence for longer.

Ankiti Bose’s Personal Longevity Journey

Ankiti Bose’s interest in longevity is also personal. Her own longevity journey began in her 30s, after years of high-pressure building, operating, media scrutiny and work stress.

That experience led her deep into diagnostics, peptides, cognitive training, neuroscience, stem cells, exosomes, hormone optimisation and other cutting-edge protocols across California, Switzerland and the UAE. She has often chosen to be the first patient within the group, testing protocols, tracking biomarkers and learning firsthand how science, data and disciplined intervention can shape healthspan.

Through this journey, and by her own account on social media, Bose has slowed her measured pace of aging to 0.77x and brought several biological-age markers to around 28, based on the biomarkers and longevity metrics she tracks.

This personal experience has shaped her approach to building in the longevity space. It gives her a patient-founder perspective on a category that sits between medicine, technology, consumer behaviour and trust.

From E-Commerce Founder to Future Health Investor

Earlier in her career, Ankiti Bose co-founded a large-scale e-commerce company in Asia focused on the fashion and supply-chain industry. Its rapid rise, scale and eventual decline taught her valuable lessons about ambition, governance, resilience, public scrutiny and building through cycles.

That chapter remains part of Bose’s story, but her current work is focused on the future: Terra-Invest, AI healthcare, longevity, preventive medicine, energy transition, finance, technology and emerging-market platforms.

Her trajectory reflects a shift from building in consumer commerce and supply chains to building and investing in sectors that may define the next decade, especially healthcare, longevity, artificial intelligence and strategic capital platforms. It places her among the longevity investors and founders to watch.

AI Education and Bharat Udyam AI Foundation

More recently, Ankiti Bose has also started working closely with local lawmakers and young people in India through the Bharat Udyam AI Foundation, supporting grassroots AI education, entrepreneurship and future-skills access.

Her work in this area reflects a broader belief that artificial intelligence should not remain limited to elite institutions or major technology hubs. For young people in India, AI education can become a pathway into entrepreneurship, productivity, economic mobility and participation in the next wave of global technology.

Why Ankiti Bose’s Work Matters Now

Ankiti Bose’s current work sits at the centre of several powerful global themes: AI healthcare, longevity, preventive medicine, diagnostics, aesthetics, energy transition, pre-IPO investing, emerging markets and institutional capital.

As healthcare becomes more personalised and data-driven, the demand for platforms that combine science, clinical care, technology, trust and consumer access is growing. Terra’s Future Health Group is positioned around this shift.

As capital increasingly moves toward sectors with long-term structural demand, Terra-Invest’s focus on healthcare, technology, finance, energy transition and pre-IPO opportunities reflects the types of markets that may define the future economy.

Who Is Ankiti Bose Today?

Today, Ankiti Bose is best understood as a Terra-Invest founding partner, longevity investor, AI healthcare builder and emerging-markets entrepreneur.

Her work spans capital, governance, artificial intelligence, healthcare, consumer trust and frontier markets. Through Terra-Invest and Terra’s Future Health Group, she is focused on building and backing companies in sectors where science, technology, brand, distribution and capital can compound together.

Beyond business, Bose speaks five languages, sings Indian classical music, and has a deep interest in art history, pop culture and cricket.

At the heart of her current work is a clear thesis: the future of healthcare will be more predictive, personalised and preventive, and the next generation of iconic companies will be built where capital, technology, trust and human health converge.

FAQ

Who is Ankiti Bose?

Ankiti Bose is a founding partner of Terra-Invest and chairperson of Terra’s Future Health Group, working across longevity, AI healthcare, preventive medicine, finance and energy transition, with a focus on the Middle East, Europe and India.

What is Terra’s Future Health Group?

It is the health arm Bose chairs, which invests in and manages AI-powered longevity, aesthetics and consumer health platforms and clinics across the Middle East and Europe, built around predictive, personalised and preventive care.

What is Ankiti Bose’s background?

She earlier co-founded a large-scale e-commerce and supply-chain company in Asia, then moved into investing and building across healthcare, longevity, artificial intelligence and strategic capital platforms.